Lawmakers Slam FTC Generic Biologic Report
The Federal Trade Commission's suggestion Thursday that 12 to 14 years of data exclusivity for generic biologics is unnecessary rankled U.S. House of Representatives commerce subcommittee members, who called for more...To view the full article, register now.
Already a subscriber? Click here to view full article